The Diagnostic Tampon invented by gynaecological health company Daye has been chosen to be part of the NHS Innovation Accelerator (NIA). The Accelerator recognises innovations that...
Cervical cancer remains a significant global health issue, affecting thousands of women each year. Early detection of precancerous cervical lesions through screening methods such as the...
A clinical trial investigating the treatment TIVDAK for cervical cancer has shown positive results. The topline results from the global Phase 3 innovaTV 301 study demonstrated...
A new, at-home cervical cancer screening test will be launched with the backing of US$10m in funding. The Teal Wand, a at-home screening device and telehealth...
Researchers are using AI to enhance detection accuracy and efficiency, paving the way for a transformation in cervical cancer screening. With the aid of deep learning...
A recent study has found that Native American women were disproportionately affected by vaginal dysbiosis, a disruption in the balance of bacterial that increases the risk...
Women are being urged to come forward for cervical screening as new figures show more than five million are not up to date with their routine...
Women’s cancer innovations will take centre stage at the second edition of the Femtech World Awards. The second annual Femtech World Awards aim to shine a...
The award-winning gynaecological health start-up Daye has expanded its revolutionary at-home tampon-based screening kit to include HPV testing. The pioneering “diagnostic tampon” already utilises cutting-edge PCR...
Self-sampling has already been introduced in several countries with the aim of increasing cervical screening participation rates
